Zevra Therapeutics, Inc. (NASDAQ:ZVRA – Get Free Report) has received a consensus rating of “Buy” from the six brokerages that are presently covering the company, MarketBeat Ratings reports. Six analysts have rated the stock with a buy recommendation. The average twelve-month price objective among analysts that have updated their coverage on the stock in the […]
RS Group (LON:RS1 – Get Free Report) had its price target decreased by stock analysts at Royal Bank of Canada from GBX 925 ($11.81) to GBX 900 ($11.49) in a note issued to investors on Wednesday, Marketbeat Ratings reports. The firm currently has an “outperform” rating on the stock. Royal Bank of Canada’s price objective […]
RS Group (LON:RS1 – Get Free Report) had its price objective cut by analysts at Royal Bank of Canada from GBX 925 ($11.81) to GBX 900 ($11.49) in a research report issued to clients and investors on Wednesday, Marketbeat Ratings reports. The brokerage currently has an “outperform” rating on the stock. Royal Bank of Canada’s […]
Mizuho upgraded shares of Norwegian Cruise Line (NYSE:NCLH – Free Report) from a neutral rating to a buy rating in a report published on Tuesday morning, MarketBeat Ratings reports. They currently have $24.00 price target on the stock, up from their previous price target of $21.00. A number of other equities research analysts have also […]
Mizuho upgraded shares of Norwegian Cruise Line (NYSE:NCLH – Free Report) from a neutral rating to a buy rating in a research report report published on Tuesday, Marketbeat Ratings reports. Mizuho currently has $24.00 price objective on the stock, up from their prior price objective of $21.00. Several other equities research analysts have also weighed […]